US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the people who need it?

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.